These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2214766)

  • 1. Differences in the form of the salt-transformed estrogen receptor when bound by estrogen versus antiestrogen.
    Ruh MF; Turner JW; Paulson CM; Ruh TS
    J Steroid Biochem; 1990 Aug; 36(6):509-16. PubMed ID: 2214766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW; Ruh MF; Ruh TS
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
    Turner JW; Ruh MF; Ward DT; Ruh TS
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF; Brzyski RG; Strange L; Ruh TS
    Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]estradiol- and [3H]H1285-receptor complexes to rabbit uterine chromatin.
    Singh RK; Ruh MF; Ruh TS
    Biochim Biophys Acta; 1984 Jul; 800(1):33-40. PubMed ID: 6743683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
    Singh RK; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
    Evans E; Baskevitch PP; Rochefort H
    Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences of the binding of estradiol and 4-hydroxytamoxifen (an antiestrogen) in the chick oviduct cytosol.
    Geynet C; Shyamala G; Baulieu EE
    Biochim Biophys Acta; 1983 Apr; 756(3):349-53. PubMed ID: 6830859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
    Katzenellenbogen BS; Ferguson ER
    Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF; Singh RK; Mak P; Callard GV
    Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an antiestrogen-binding protein in high salt extracts of human breast cancer tissue.
    Kon OL
    J Steroid Biochem; 1985 Feb; 22(2):177-86. PubMed ID: 3982029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.